Octapharma - clicking the octapharma logo will load the homepage
Terms of use
Octapharma News
The Company
Business Areas
People
Management Board
Milestones
Financial
Philanthropic Endeavors
8 Questions to Octapharma
Products & Therapeutic Areas
Research & Development
Production
Worldwide Contacts
Career
Expand Menu

 

Management Board


The management board of the Octapharma Group is a diverse mix of Danish, British, Portuguese, and German nationals. The fact that the Board is not dominated by one nationality ensures that Management decisions are taken with the widest possible cultural representation.

Wolfgang Marguerre
Chairman, Octapharma Group

"Responsibility is not something you get, but something you take"


Kim Björnstrup
Vice Chairman, Octapharma Group

"Our strength is that we have continued to develop our knowledge in protein purification. This now comes to good use in our recombinant protein research. In addition we have been able to maintain a short process of decision making which attracts people with ambitions to create results."


Karl Erik Clausen
Chief Financial Officer

"
The continuous improvement of the solid financial position of the Octapharma Group is an excellent platform for future profitable growth."


Nicholas Jacobson
Chief Operating Officer

"Our strength is customer oriented flexibility in all production units."


Reinhard Rettinghaus
General Manager, Octapharma GmbH

"GmbH's product portfolio is designed to meet the needs of the German market in terms of high quality standards, safety features and variety of product presentations. Our market position continues to strengthen across all Octapharma product lines as a result of our steadfast dedication to exceed the market norm in both products and service."


Paulo Castro
General Manager for the
Iberian Peninsula, Brazil and Latin America


"Among the key drivers that continue to guarantee a distinctive presence of Octapharma in the market is not only the quality of our products and astute strategic planning but also a quick and objective decision-making process."


Tobias Marguerre
President for Octapharma Nordic AB

"The Octapharma difference is our ability to stay one step ahead of the competition, anticipate our customers’ needs, and act swiftly to meet those needs through streamlined decision making processes.  All the employees at Octapharma possess an entrepreneurial spirit that is visible through their creativity, initiative, and remarkable ambition to reach for personal, professional, and the company’s best results."


Frederic Marguerre
Member of the Board,
Intl. Sales, Corporate Customer Service and Plasma Procurement

“The four pillars of our success are its growing state of the art product portfolio, balanced sales, fiscal health and human assets. “




Flemming Nielsen
President for Octapharma USA Inc.

Trust is not just a slogan, it is a way of life. Octapharma partners with health care providers and patients to provide them with every reason to trust in our products. From starting materials “




Dennis Curtin
President Octapharma Plasma, Inc., USA

“Establishing and maintaining trust is the keystone to the strong and successful relationships that we enjoy with our suppliers in the plasma industry. However trust is earned, and can only exist when the relationship is defined by open and frank communication, flexibility, and contracts that are fair to both parties. Once trust is established, the business relationship with our suppliers becomes more of a partnership. “